Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03411057 · ClinicalTrials.gov registry record
Mindfulness Based Stress Reduction in Rheumatic Diseases
A clinical trial, sponsored by Johns Hopkins University.
- Terminated
- Registry status
- 5
- Enrollment target
NCT03411057: Clinical Trial study, sponsored by Johns Hopkins University.
NCT03411057 is a clinical trial that was terminated before completion, run by Johns Hopkins University. The registered enrollment target is 5 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03411057 was terminated before completion, sponsored by Johns Hopkins University.
- TERMINATED
- Registry status
- 5 participants
- Enrollment target
Study Summary
This study will assess the mental health and clinical benefits of Mindfulness Based Stress Reduction (MBSR) in patients with rheumatic disease who have anxiety or depression. MBSR, an interactive form of meditation that includes gentle yoga, will be taught by a certified instructor over an eight-week period. Mental health surveys will be conducted within one month of the study start and end as well as mid-course. Clinical assessments will be conducted within one-month of the study start and end.
Primary Outcome
Patient Reported Outcomes Measurement Information System (PROMIS) Anxiety Scale (8a). The PROMIS Anxiety Scale is measured as a t score with a t-score range from 41 (less anxious) to 80 (highly anxious). For most PROMIS instruments, a score of 50 is the average for the United States general population with a standard deviation of 10.
Interventions
- OTHER Control
- BEHAVIORAL Mindfulness Based Stress Reduction (MBSR)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2018-01-18 |
| Est. Completion | 2021-04-22 |
Why NCT03411057 stopped before completion
NCT03411057 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 5 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Control is the first listed.
NCT03411057 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03411057 about?
NCT03411057 is a clinical study titled "Mindfulness Based Stress Reduction in Rheumatic Diseases". This study will assess the mental health and clinical benefits of Mindfulness Based Stress Reduction (MBSR) in patients with rheumatic disease who have anxiety or depression. MBSR, an interactive form of meditation that includes gentle yoga, will be taught by a certified instructor over an eight-wee...
What is the current status of trial NCT03411057?
This trial is currently terminated. The enrollment target is 5 participants. The study started on 2018-01-18. Estimated completion is 2021-04-22.
What interventions are being tested in trial NCT03411057?
The interventions under investigation include: Control (OTHER), Mindfulness Based Stress Reduction (MBSR) (BEHAVIORAL).
Who is sponsoring clinical trial NCT03411057?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI